scholarly article | Q13442814 |
P50 | author | Sonia Fargue | Q43091297 |
P2093 | author name string | Gill Rumsby | |
Christopher J Danpure | |||
P433 | issue | 10 | |
P921 | main subject | pyridoxine | Q423746 |
primary hyperoxaluria | Q7243137 | ||
P304 | page(s) | 1776-1783 | |
P577 | publication date | 2013-04-15 | |
P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
P1476 | title | Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1. | |
P478 | volume | 1832 |
Q36997186 | Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria |
Q30834734 | Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type |
Q40015456 | Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. |
Q90280443 | Endpoints for Clinical Trials in Primary Hyperoxaluria |
Q36188475 | Engineering a pyridoxal 5'-phosphate supply for cadaverine production by using Escherichia coli whole-cell biocatalysis |
Q63441475 | Factors influencing clinical outcome in patients with primary hyperoxaluria type 1 |
Q47602222 | Folding Defects Leading to Primary Hyperoxaluria |
Q36145370 | High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1 |
Q92439241 | Importance of Assessing Compliance with Conservative Treatment of Primary Hyperoxaluria Type 1: A Case Report of a Patient with I244T/c.969-3C>G Mutation |
Q38200933 | Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators. |
Q34935451 | Kidney stones in primary hyperoxaluria: new lessons learnt |
Q42182786 | Molecular recognition of PTS-1 cargo proteins by Pex5p: implications for protein mistargeting in primary hyperoxaluria. |
Q34407663 | Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. |
Q36104822 | Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria |
Q36432868 | Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure |
Q38292247 | Primary hyperoxalurias: diagnosis and treatment |
Q29147458 | Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria |
Q30355120 | Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies. |
Q50576688 | Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. |
Q90395008 | Recent advances in the identification and management of inherited hyperoxalurias |
Q34379056 | S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation |
Q53170036 | SNP Variants in RET and PAX2 and Their Possible Contribution to the Primary Hyperoxaluria Type 1 Phenotype. |
Q35977167 | Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant |
Q58609046 | The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria |
Q98463100 | The ILE56 mutation on different genetic backgrounds of alanine: Glyoxylate aminotransferase: Clinical features and biochemical characterization |
Q27680557 | The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I |
Q37267462 | Two novel AGXT mutations identified in primary hyperoxaluria type-1 and distinct morphological and structural difference in kidney stones |
Q57818861 | Updated Genetic Testing of Primary Hyperoxaluria Type 1 in a Chinese Population: Results from a Single Center Study and a Systematic Review |
Q37621553 | Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice |
Search more.